相关实验视频
Updated: Aug 1, 2026

07:54
Cholesterol Efflux Assay
Published on: March 6, 2012
降低胆固醇产生临床益处:他类药物试验的影响
A L Gould1, J E Rossouw, N C Santanello
1Merck Research Laboratories, West Point, PA 19486, USA. goulda@merck.com
Circulation
|April 7, 1998
概括
纳入新的他类药物试验数据加强了证据,表明降低胆固醇可以显著降低冠心病和总死亡率的风险. 类药物提供与其降脂效应成比例的临床益处,而不会增加非冠状动脉心脏病死亡率.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 公共卫生 公共卫生
背景情况:
- 之前的元分析评估了降低胆固醇的临床益处.
- 发表了8项关于Hmg CoA减少酶抑制剂 (他类药物) 的新试验.
研究的目的:
- 为了确定新的他类药物试验结果对以前的元分析结论的影响.
- 重新评估降低胆固醇的临床益处.
主要方法:
- 使用与之前的元分析相同的分析方法.
- 降低胆固醇与干预类型的单独影响.
- 结合了最近八项他类药物试验的研究结果.
主要成果:
- 通过使用他类药物观察到的冠心病 (CHD) 和总死亡率的风险降低与之前的预测一致.
- 新的分析预测,每10%降低胆固醇,心血管疾病死亡风险降低15%,总死亡风险降低11%.
- 降低胆固醇,特别是通过他类药物,并没有增加非心脏病死亡风险.
结论:
- 新的他类药物试验数据证实,降低胆固醇是临床上有益的.
- 降低胆固醇和降低死亡风险之间的关系变得更加强烈.
- 立方体对死亡率的影响是由降脂能力解释的,并且与降脂成比例.
相关概念视频
Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Cholesterol: Significance and Regulation
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

